Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
19:55:00 03/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 198.60 EUR | +0.35% |
|
+0.97% | -5.43% |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| 08-20 | European stock markets slip as oil prices surge again |  |
| Market Cap | 19.32B 22.46B 18.13B 16.59B 30.96B 2,123B 31.21B 215B 83.54B 1,085B 84.34B 82.5B 3,494B | P/E 2026 * |
50.6x | P/E 2027 * | 39.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.33B 24.79B 20.02B 18.31B 34.18B 2,344B 34.45B 237B 92.22B 1,198B 93.1B 91.07B 3,857B | EV / Sales 2026 * |
6.82x | EV / Sales 2027 * | 6.08x |
| Free-Float |
28.47% | Yield 2026 * |
0.42% | Yield 2027 * | 0.51% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| DIM | Real-time | |
CBOE
| DIMp | Real-time | |
|
Börse Stuttgart
| 56S1 | Delayed | |
|
Tradegate
| 56S1 | Real-time | |
|
CBOE
| 0NK7 | Real-time | |
|
OTC Markets
| SDMHF | Delayed | |
|
Boerse Muenchen
| 56S1 | Real-time | |
|
Xetra
| 56S1 | Delayed | |
|
Deutsche Boerse AG
| 56S1 | Delayed | |
|
London S.E.
| 0NK7 | Delayed | |
|
Borsa Italiana
| 4DIM | End-of-day quote | |
|
Wiener Boerse
| DIM | End-of-day quote |
Last Transcript : Sartorius Stedim Biotech
| 1 day | +0.35% | ||
| 1 week | +0.97% | ||
| Current month | +1.33% | ||
| 1 month | +15.53% | ||
| 3 months | +12.52% | ||
| 6 months | +18.89% | ||
| Current year | -5.43% |
| 1 week | 192.8 |  | 203 |
| 1 month | 169.8 | | 203 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 281 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 28/03/2023 |
| Chief Tech/Sci/R&D Officer | 61 | 08/09/2011 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 07/04/2015 | |
Susan Dexter
BRD | Director/Board Member | 69 | 07/04/2015 |
Lothar Kappich
BRD | Director/Board Member | 69 | 14/09/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/12/25 | Sell | Company | 750,000 | 0.7706% | ||
| 16/02/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 02/03/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.35% | +0.97% | +13.97% | -24.57% | 22.32B | |
| -1.52% | -2.51% | -17.70% | +5.78% | 191B | |
| +1.00% | +3.48% | +0.92% | +13.36% | 118B | |
| +0.26% | +4.98% | +14.26% | +92.74% | 64.19B | |
| +0.29% | +0.51% | +24.42% | +49.21% | 51.49B | |
| +0.05% | -0.27% | -1.05% | -32.62% | 51.08B | |
| +0.02% | +0.47% | +13.67% | -11.96% | 33.85B | |
| +0.80% | +5.60% | - | - | 31.85B | |
| +0.03% | -0.97% | +37.67% | -15.93% | 24.11B | |
| -1.32% | -4.10% | -7.26% | +12.11% | 22.96B | |
| Average | -0.00% | -0.08% | +8.77% | +9.79% | 61.1B | |
| Weighted average by Cap. | -0.22% | -0.73% | +0.62% | +14.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.63B 2.93B 2.68B 5.01B 344B 5.05B 34.71B 13.52B 176B 13.65B 13.35B 565B | 3.47B 4.03B 3.26B 2.98B 5.56B 381B 5.6B 38.51B 15B 195B 15.14B 14.81B 627B |
| Net income | 381M 443M 358M 327M 611M 41.9B 616M 4.23B 1.65B 21.41B 1.66B 1.63B 68.96B | 483M 562M 453M 415M 774M 53.08B 780M 5.36B 2.09B 27.13B 2.11B 2.06B 87.36B |
| Net Debt | 2.01B 2.33B 1.88B 1.72B 3.22B 221B 3.24B 22.29B 8.68B 113B 8.76B 8.57B 363B | 1.76B 2.04B 1.65B 1.51B 2.81B 193B 2.84B 19.49B 7.59B 98.56B 7.66B 7.49B 317B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | €198.60 | +0.35% | 79,897 |
| 02/09/26 | €197.90 | +1.33% | 93,408 |
| 01/09/26 | €195.30 | -0.36% | 120,335 |
| 31/08/26 | €196.00 | -0.86% | 219,124 |
| 28/08/26 | €197.70 | +0.51% | 56,919 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
